TLDR Cameco shares climbed 1.6% to $123.86 on Friday, with trading volume 24% below average at 3.39 million shares Analysts maintain a “Buy” rating with an averageTLDR Cameco shares climbed 1.6% to $123.86 on Friday, with trading volume 24% below average at 3.39 million shares Analysts maintain a “Buy” rating with an average

Cameco (CCJ) Stock: Uranium Play Climbs Despite Earnings Miss – Time to Buy?

2026/01/25 23:09
4 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Cameco shares climbed 1.6% to $123.86 on Friday, with trading volume 24% below average at 3.39 million shares
  • Analysts maintain a “Buy” rating with an average price target of $121.68, though current trading exceeds this target
  • The company missed Q3 estimates with $0.05 EPS versus $0.22 expected and revenue down 14.7% year-over-year
  • Cameco doubled its annual dividend from $0.12 to $0.24, representing a 27% yield at current prices
  • Wall Street remains split with two Strong Buy, 12 Buy, and two Hold ratings from 16 analysts covering the stock

Cameco shares moved higher on Friday, closing at $123.86 after gaining 1.6% during the trading session. The stock reached an intraday high of $124.11 before settling just below that mark.


CCJ Stock Card
Cameco Corporation, CCJ

Trading volume told a different story. Only 3.39 million shares changed hands, roughly 24% below the average daily volume of 4.45 million shares. The lighter trading activity came as the stock pushed higher from Thursday’s close of $121.87.

The price action comes weeks after the company reported disappointing third-quarter results. Cameco posted earnings per share of $0.05, missing analyst expectations of $0.22 by a wide margin. Revenue came in at $313.74 million, falling short of the $531.72 million consensus estimate.

Year-over-year comparisons weren’t pretty either. Revenue dropped 14.7% compared to the same quarter last year. The company posted a loss of $0.01 per share in the prior-year period, making the positive $0.05 EPS a relative improvement despite missing current estimates.

The company now trades at a lofty valuation. With a market cap of $53.94 billion and a P/E ratio of 144.02, investors are paying a premium. The stock sits well above its 50-day moving average of $95.51 and its 200-day moving average of $86.90.

Analyst Ratings Paint Mixed Picture

Wall Street analysts maintain a generally positive outlook. Two analysts rate the stock a Strong Buy, while 12 have Buy ratings. Two analysts issued Hold ratings. The average price target stands at $121.68, which actually sits below Friday’s closing price.

Recent analyst moves show continued support. Raymond James reaffirmed an “outperform” rating on January 14th. Goldman Sachs raised its price target from $95 to $109 back in October, maintaining a Buy rating.

Not everyone shares the enthusiasm. Wall Street Zen downgraded shares from Buy to Hold in early November. Weiss Ratings maintained a “hold (c-)” rating in late December. GLJ Research set a more conservative price target of $99.74 while keeping a Buy rating.

The company’s balance sheet shows strength in some areas. Cameco maintains a debt-to-equity ratio of 0.15, indicating low leverage. The quick ratio of 1.85 and current ratio of 2.99 suggest solid liquidity.

Dividend Doubles Despite Revenue Decline

Cameco made a surprising move in December. The company doubled its annual dividend from $0.12 to $0.24 per share. The dividend was paid on December 16th to shareholders of record as of December 1st.

The payout ratio sits at 19.77%, leaving plenty of room for future increases. At Friday’s closing price, the dividend represents a 27% yield, though that calculation appears to use annualized figures.

Institutional investors continue to adjust their positions. Financial Consulate Inc. initiated a new stake worth $25,000 in the third quarter. Nisa Investment Advisors and Founders Capital Management also established positions in the fourth quarter.

Trust Co. of Vermont made a bigger move. The firm increased its position by 1,029.4% in the second quarter, bringing its total to 384 shares valued at $29,000. Institutional investors now own 70.21% of the company’s outstanding shares.

Analysts project full-year earnings of $1.27 per share. The company reported a net margin of 15.24% and return on equity of 8.58% in the most recent quarter. The beta of 1.01 suggests the stock moves roughly in line with the broader market.

The post Cameco (CCJ) Stock: Uranium Play Climbs Despite Earnings Miss – Time to Buy? appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

$30,000 in PRL + 15,000 USDT

$30,000 in PRL + 15,000 USDT$30,000 in PRL + 15,000 USDT

Deposit & trade PRL to boost your rewards!